Patents by Inventor Niels Taekker Foged

Niels Taekker Foged has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8731845
    Abstract: The present invention relates to methods for identifying and optionally quantifying stained cells in a cell or tissue sample and determining expression level of a target, as well as methods for determining staining intensity and/or staining quality of a stained sample, calibrating digital imaging apparatus using the methods, as well as systems and a computer readable mediums therefore.
    Type: Grant
    Filed: August 14, 2009
    Date of Patent: May 20, 2014
    Assignee: Visionpharm A/S
    Inventors: Michael Grunkin, Niels Tækker Foged
  • Publication number: 20110234812
    Abstract: The present invention relates to methods for identifying and optionally quantifying stained cells in a cell or tissue sample and determining expression level of a target, as well as methods for determining staining intensity and/or staining quality of a stained sample, calibrating digital imaging apparatus using the methods, as well as systems and a computer readable mediums therefore.
    Type: Application
    Filed: August 14, 2009
    Publication date: September 29, 2011
    Applicant: Visiopharm A/S
    Inventors: Michael Grunkin, Niels Taekker Foged
  • Patent number: 6110470
    Abstract: A vaccine for immunizing animals against diseases caused by microorganisms producing an osteolytic toxin comprising an immunologically effective amount of a recombinant, immunogenic, detoxified Pasteurella multocida toxin or toxin analog, the vaccine being encoded by a nucleotide sequence coding for a Pasteurella multocida toxin or toxin analog which is inserted in an expression vector capable of replicating in a suitable host microorganism in which the said sequence may be expressed. Optionally, the produced toxin or toxin analog is subjected to posttranscriptional modifications to provide the detoxified toxin or toxin analog. Alternatively, the nucleotide sequence may be modified prior to insertion into the expression vector so as to provide the toxin or toxin analog in a detoxified form.
    Type: Grant
    Filed: August 22, 1994
    Date of Patent: August 29, 2000
    Assignee: Akzo Nobel N.V.
    Inventors: Niels Taekker Foged, Svend Petersen